LP
OCUL icon

LMR Partners’s Ocular Therapeutix OCUL Stock Holding History

LMR Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Sell
20,000
-63,300
-76% -$603K ﹤0.01% 1213
2025
Q4 		$1.01M Buy
+83,300
New +$1.01M ﹤0.01% 981

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LMR Partners's OCUL Position: Q1 2026 in Review

LMR Partners opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 2,728 shares worth $23.1K. The stake represents ﹤0.01% of the portfolio and ranks #1342 among its holdings.

269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • LMR Partners held 2,728 shares of Ocular Therapeutix worth $23.1K as of Q1 2026.
  • Ocular Therapeutix was a new LMR Partners position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1342 holding.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.